Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)

Funding Opportunity PAR-19-100 from the NIH Guide for Grants and Contracts. The Clinical and Translational Science Award (CTSA) Program Collaborative Innovation Award (CCIA) supports collaborative research activities that develop innovative solutions that will improve the efficiency, quality and impact of turning laboratory, clinic and community observations into interventions that improve the health of individuals and the public. This funding opportunity announcement (FOA) will support investigators from two or more CTSA Program hub institutions (see below under Eligible Individuals) to either: 1) form new collaborations, or to 2) significantly expand the scientific scope of existing collaborations, or to 3) engage new collaborators in pre-existing collaborations to address the purpose of this FOA. The purpose of this funding opportunity announcement (FOA) is to support highly innovative, exploratory, and collaborative research projects in the CTSA Program, with the goal of assessing utility and feasibility of proposed innovation(s).
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding